Securities Code: 301015
Bond Code: 123194
Company Name: Qingdao Baiyang Pharmaceutical Co., Ltd.
Abbreviation: Baiyang Pharmaceutical
Announcement No.: 2026-053
Abbreviation: Baiyang Transfer
Qingdao Baiyang Pharmaceutical Co., Ltd.
Announcement on the Resolution of the Second Extraordinary General Meeting in 2026
This announcement contains true, accurate, and complete information regarding the disclosure of information by the Company and its board of directors, and does not contain any false records, misleading statements, or significant omissions.
Special Notice:
-
This general meeting did not encounter any voting-related situations.
-
This general meeting did not involve any changes or amendments to the resolutions previously passed.
I. Convening and Holding of the Meeting
(I) Convening of the Meeting
- Meeting Time:
(1) On-site meeting time: June 26, 2026 (Thursday) 14:30
(2) Online voting time: Through the online voting system of the Shenzhen Stock Exchange from 9:15 to 9:25 on June 26, 2026; through the Shenzhen Stock Exchange online voting platform from 9:15 to 15:00 on June 26, 2026.
-
Meeting Venue: Conference Room 1, Building 88, Beihai Road, Jiaozhou City, Shandong Province, Qingdao Baiyang Pharmaceutical Co., Ltd.
-
Meeting Method: This general meeting adopted a combination of on-site voting and online voting.
-
Conveners: Board of Directors
-
Presiding Officer: Mr. Chang Jin, Chairman
The meeting was convened and held in accordance with the provisions of relevant laws, administrative regulations, and the Company's Articles of Association.
(II) Overview of Meeting Attendance
- Total number of shareholders attending the meeting: The number of shareholders and authorized representatives attending the meeting was 98, representing the number of voting shares.
358,941,595 shares, accounting for 68.2887% of the total voting shares of the Company. Among them: 1 shareholder and authorized representative attended the on-site meeting, representing 353,309,710 voting shares, accounting for 67.2172% of the total voting shares; 97 shareholders attended the meeting via online voting, representing 5,631,885 voting shares, accounting for 1.0715% of the total voting shares.
- The Company's directors, the secretary of the board, and the witnessing lawyers attended the meeting, and other senior management personnel were present.
II. Review and Voting on Proposals
(I) Voting Method for Proposals: This general meeting adopted a combination of on-site voting and online voting.
(II) Review and Voting on Proposals:
- The proposal "Regarding the Company's Issuance of H Shares and Listing on the Main Board of The Stock Exchange of Hong Kong Limited" was deliberated and approved.
Total voting:
358,562,295 shares in favor, accounting for 99.8943% of the total valid voting shares attending the meeting;
379,300 shares against, accounting for 0.1057% of the total valid voting shares attending the meeting;
0 shares abstained (including 0 shares abstained due to non-voting), accounting for 0.0000% of the total valid voting shares attending the meeting.
Total voting of small and medium shareholders:
5,252,585 shares in favor, accounting for 93.2651% of the total valid voting shares of small and medium shareholders attending the meeting;
379,300 shares against, accounting for 6.7349% of the total valid voting shares of small and medium shareholders attending the meeting;
0 shares abstained (including 0 shares abstained due to non-voting), accounting for 0.0000% of the total valid voting shares of small and medium shareholders attending the meeting.
Voting Result: This matter is a special resolution, which was passed by more than 2/3 of the total voting shares of those attending the meeting.
- The proposal "Regarding the Plan for the Company's Issuance of H Shares and Listing on The Stock Exchange of Hong Kong Limited" was deliberated and approved item by item.
2.01. Listing Location
358,590,095 shares in favor, accounting for 99.9021% of the total valid voting shares attending the meeting;